![](/img/cover-not-exists.png)
Axicabtagene ciloleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median
Messori, Andrea, Chiumente, Marco, Mengato, DanieleVolume:
12
Journal:
Therapeutic Advances in Medical Oncology
DOI:
10.1177/1758835920930643
Date:
January, 2020
File:
PDF, 161 KB
2020